Medicus Pharma Ltd. (MDCXW) EBITDA (2024 - 2026)
Medicus Pharma's (MDCXW) quarterly EBITDA came in at -$7.8 million in Q4 2025, down 117.28% YoY from $45.1 million in Q4 2024, and down 51937233.33% on a QoQ basis from -$15.0 in Q3 2025.
Medicus Pharma Ltd. (MDCXW) EBITDA (2024 - 2026) Analysis & Trends
Medicus Pharma (MDCXW) has 2 years of EBITDA data on file, last reported at -$7.8 million in Q4 2025.
- Quarterly EBITDA fell 117.28% year-over-year to -$7.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$18.9 million (down 69.33% YoY) and the FY2025 annual result came in at -$34.4 million, down 207.3% from the prior year.
- EBITDA fell to -$7.8 million in Q4 2025, from -$15.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$15.0 in Q3 2025 to a low of -$7.8 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.48 Mn |
| Dec 31, 2025 | -7.79 Mn |
| Sep 30, 2025 | -15.00 |
| Jun 30, 2025 | -6.02 Mn |
| Mar 31, 2025 | -5.13 Mn |
| Dec 31, 2024 | -3.59 Mn |
| Sep 30, 2024 | -2.33 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Mar 31, 2024 | -1.71 Mn |